A large‐scale production of mesenchymal stem cells and their exosomes for an efficient treatment against lung inflammation
- 25 February 2024
- journal article
- research article
- Published by Wiley in Biotechnology Journal
- Vol. 19 (2) , e2300174
Abstract
Mesenchymal stem cells (MSCs) and their produced exosomes have demonstrated inherent capabilities of inflammation‐guided targeting and inflammatory modulation, inspiring their potential applications as biologic agents for inflammatory treatments. However, the clinical applications of stem cell therapies are currently restricted by several challenges, and one of them is the mass production of stem cells to satisfy the therapeutic demands in the clinical bench. Herein, a production of human amnion‐derived MSCs (hMSCs) at a scale of over 1 × 109 cells per batch was reported using a three‐dimensional (3D) culture technology based on microcarriers coupled with a spinner bioreactor system. The present study revealed that this large‐scale production technology improved the inflammation‐guided migration and the inflammatory suppression of hMSCs, without altering their major properties as stem cells. Moreover, these large‐scale produced hMSCs showed an efficient treatment against the lipopolysaccharide (LPS)‐induced lung inflammation in mice models. Notably, exosomes collected from these large‐scale produced hMSCs were observed to inherit the efficient inflammatory suppression capability of hMSCs. The present study showed that 3D culture technology using microcarriers coupled with a spinner bioreactor system can be a promising strategy for the large‐scale expansion of hMSCs with improved anti‐inflammation capability, as well as their secreted exosomes.Keywords
Funding Information
- Fundamental Research Funds for the Central Universities (226‐2022‐00125)
- National Natural Science Foundation of China (U22A20383)
- Natural Science Foundation of Zhejiang Province (LD22H300002)
This publication has 50 references indexed in Scilit:
- Regulation of Osteoimmune Microenvironment and Osteogenesis by 3D‐Printed PLAG/black Phosphorus Scaffolds for Bone RegenerationAdvanced Science, 2023
- ECM‐Inspired Hydrogels with ADSCs Encapsulation for Rheumatoid Arthritis TreatmentAdvanced Science, 2023
- Intravenous injection of mesenchymal stem cell spheroids improves the pulmonary delivery and prolongs in vivo survivalBiotechnology Journal, 2021
- Mesenchymal Stem Cells‐Based Targeting Delivery System: Therapeutic Promises and Immunomodulation against TumorAdvanced Therapeutics, 2021
- Umbilical cord derived mesenchymal stromal cells in microcarrier based industrial scale culture sustain the immune regulatory functionsBiotechnology Journal, 2021
- Dimethyloxalylglycine, a small molecule, synergistically increases the homing and angiogenic properties of human mesenchymal stromal cells when cultured as 3D spheroidsBiotechnology Journal, 2021
- Substrate Curvature Restricts Spreading and Induces Differentiation of Human Mesenchymal Stem CellsBiotechnology Journal, 2017
- Stirred tank bioreactor culture combined with serum‐/xenogeneic‐free culture medium enables an efficient expansion of umbilical cord‐derived mesenchymal stem/stromal cellsBiotechnology Journal, 2016
- Systematic microcarrier screening and agitated culture conditions improves human mesenchymal stem cell yield in bioreactorsBiotechnology Journal, 2015
- A quantitative approach for understanding small‐scale human mesenchymal stem cell culture – implications for large‐scale bioprocess developmentBiotechnology Journal, 2013